Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
3.100
+0.160 (5.44%)
Dec 20, 2024, 4:00 PM EST - Market closed
Tango Therapeutics Employees
Tango Therapeutics had 140 employees as of December 31, 2023. The number of employees increased by 30 or 27.27% compared to the previous year.
Employees
140
Change (1Y)
30
Growth (1Y)
27.27%
Revenue / Employee
$309,879
Profits / Employee
-$881,393
Market Cap
333.00M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 140 | 30 | 27.27% |
Dec 31, 2022 | 110 | 19 | 20.88% |
Dec 31, 2021 | 91 | 14 | 18.18% |
Dec 31, 2020 | 77 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Valneva SE | 676 |
Revance Therapeutics | 597 |
Sage Therapeutics | 487 |
Kamada | 378 |
NeuroPace | 171 |
Absci | 155 |
Silence Therapeutics | 109 |
Eton Pharmaceuticals | 30 |
TNGX News
- 18 days ago - Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 24 days ago - Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 6 weeks ago - Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights - Business Wire
- 6 weeks ago - Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program - Business Wire
- 3 months ago - Tango Therapeutics: Amgen Missteps Devalue PRMT5 Candidates Ahead Of Critical Data - Seeking Alpha
- 4 months ago - Tango Therapeutics to Participate in Upcoming Investor Conferences - Business Wire
- 4 months ago - Tango Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights - Business Wire
- 7 months ago - Tango Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire